$EQ 3 SEC Filings

Filed On	Filing
12 Dec 2024	Form 3: Colabuono Peter, Director No securities owned
08 Mar 2024	Form 3: Tom Penny, Principal Accounting Officer Holds 33,857 shares of Common Stock
08 Mar 2022	Form 3: Troupin Barbara, Director No securities owned
16 Feb 2021	Form 3: Decheng Capital Global Life Sciences Fund IV, L.p., 10% owner and 2 others Holds 3,285,710 shares of Common Stock
05 Feb 2021	Form 3: Xu Yu (Katherine), Director Holds 0 shares of No securities are beneficially owned
29 Jan 2021	Form 3: Rothman Joel, Chief Development Officer Holds 15,249 shares of Common Stock
13 Jan 2021	Form 3: Thomas Dolca, Chief Medical Officer Holds 0 shares of No securities are beneficially owned
02 Jan 2020	Form 3: Zedelmayer Christine, Sr. Vice President and COO Holds 70,810 shares of Common Stock
12 Oct 2018	Form 3: Manian Bala S, Director Holds 23,799 shares of Common Stock
11 Oct 2018	Form 3: McDermott Charles Douglas, Director Holds 23,799 shares of Common Stock
11 Oct 2018	Form 3: Biocon Sa, 10% owner Holds 2,088,074 shares of Common Stock
11 Oct 2018	Form 3: Polu Krishna R, Chief Medical Officer
11 Oct 2018	Form 3: Keyes Jason A, Chief Financial Officer Holds 148,720 shares of Common Stock
11 Oct 2018	Form 3: Connelly Stephen, Director Holds 1,293,000 shares of Common Stock
11 Oct 2018	Form 3: Demski Martha J, Director Holds 23,799 shares of Common Stock
11 Oct 2018	Form 3: Steel Bruce D., Director Holds 3,232,500 shares of Common Stock
11 Oct 2018	Form 3: Bradbury Daniel, Director Holds 732,700 shares of Common Stock
11 Oct 2018	Form 3: Pruzanski Mark, Director Holds 23,799 shares of Common Stock

Comments